Compare Crown Castle International Corp (CCI) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crown Castle International Corp vs Charles River Laboratories Intl. Inc — how do they compare? Crown Castle International Corp trades at $73.39 (market cap $31.33B), while Charles River Laboratories Intl. Inc trades at $287.99 (market cap $13.46B). The key difference: Crown Castle International Corp is far larger — about 2.3× Charles River Laboratories Intl. Inc's market cap, and Crown Castle International Corp pays a 5.77% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CCI | CRL | |
|---|---|---|
Market Cap | $31.33B | $13.46B |
Sector | Real Estate | Health |
52-Week High | $103.79 | $282.00 |
52-Week Low | $73.61 | $145.57 |
Enterprise Value | $53.69B | $16.30B |
Dividend Yield | 5.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crown Castle International Corp
Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.
Read more on CCI →About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →
